Suchergebnisse - "Thulborn, Samantha J"

PubPharm (7)

1

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2) : a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Ramakrishnan, S. | Jeffers, H. | Langford-Wiley, B. | +15

ErratumIn: Lancet Respir Med. 2023 Dec;11(12):e98. - PMID 38030376

2

Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD

enthalten in: The European respiratory journal | 2020

von Thulborn, S. | Cane, J. | Connolly, C. | +6

3

Detection of Cell-Dissociated Non-Typeable Haemophilus influenzae in the Airways of Patients with Chronic Obstructive Pulmonary Disease

enthalten in: International journal of chronic obstructive pulmonary disease | 2020

von Thulborn, S. | Ceroni, A. | Haldar, K. | +5

4

Neutrophil elastase as a biomarker for bacterial infection in COPD

enthalten in: Respiratory research | 2019

von Thulborn, S. | Mistry, V. | Brightling, C. | +3

5

Neutrophil elastase as a biomarker for bacterial infection in COPD

enthalten in: Respiratory research | 2019

von Thulborn, S. | Mistry, V. | Brightling, C. | +3

6

Neutrophil elastase as a biomarker for bacterial infection in COPD

enthalten in: Respiratory research | 2019

von Thulborn, S. | Mistry, V. | Brightling, C. | +3

7

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD

enthalten in: International journal of chronic obstructive pulmonary disease | 2017

von Thulborn, S. | Dilpazir, M. | Haldar, K. | +4

1
[1]